Cybin (HELP) Change in Working Capital (2020 - 2025)
Cybin (HELP) posted quarterly Change in Working Capital of -$37.8 million for Q4 2025, down 101.67% year-on-year from $2.3 billion in Q4 2024, and down 37.93% on a QoQ basis from -$27.4 million in Q3 2025.
Cybin (HELP) Change in Working Capital (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Change in Working Capital for 6 consecutive years, with -$37.8 million the latest figure, recorded in Q4 2025.
- Quarterly Change in Working Capital fell 101.67% year-over-year to -$37.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$109.8 million (down 89.86% YoY) and the FY2021 annual result came in at -$13.4 million, changed N/A from the prior year.
- Change in Working Capital declined to -$37.8 million in Q4 2025 per HELP's latest filing, from -$27.4 million in the prior quarter.
- Over the last five years, Change in Working Capital for HELP reached as high as -$5.4 million in Q1 2021 and fell as low as -$37.8 million in Q4 2025.
- A 5-year average of -$14.3 million and a median of -$9.5 million in 2021 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2021 — Change in Working Capital sank 555.47% — and 2022, when it grew 15.46%.
- Year by year, Change in Working Capital stood at -$9.5 million in 2021, then climbed by 15.46% to -$8.0 million in 2022, then plunged by 62.0% to -$13.0 million in 2023, then sank by 44.58% to -$18.8 million in 2024, then sank by 101.67% to -$37.8 million in 2025.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$37.8 million, -$27.4 million, and -$25.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.82 Mn |
| Dec 31, 2025 | -37.82 Mn |
| Sep 30, 2025 | -27.42 Mn |
| Sep 30, 2025 | -27.42 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Dec 31, 2024 | -18.76 Mn |
| Dec 31, 2024 | -18.76 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Dec 31, 2022 | -8.01 Mn |
| Dec 31, 2022 | -8.01 Mn |